Kidney Res Clin Pract.  2019 Dec;38(4):517-524. 10.23876/j.krcp.19.078.

Clinical features and outcomes in kidney transplant recipients with renal cell carcinoma: a single-center study

Affiliations
  • 1Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea. bch393@naver.com
  • 2Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.
  • 3Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Rebublic of Korea.

Abstract

BACKGROUND
Previous studies have recommended a 2- to 5-year waiting time prior to kidney transplantation (KT) in patients with end-stage renal disease (ESRD) and symptomatic renal cell carcinoma (RCC) and no delay for incidental early-stage RCC. Data on Asian KT recipients are unavailable.
METHODS
This is a Korean single-center retrospective study on 35 KT recipients with ESRD and RCC. Patients were classified into two groups: early KT (KT performed within 1 year after nephrectomy for RCC, including KT with simultaneous nephrectomy) and delayed KT (KT performed over than 1 year after nephrectomy for RCC). Patient survival, graft survival, and cancer recurrence were compared between both groups.
RESULTS
There were no statistically significant differences in patient survival (P = 0.388), graft survival (P = 0.317), or graft rejection rate (P = 0.207) between the early and delayed KT groups. Additionally, there were no differences in pathological characteristics or RCC stage other than cancer histology: acquired cystic disease-associated RCC (47.4%) was the most common RCC type in the early KT group, whereas clear cell type (62.5%) was the most common RCC type in the delayed KT group. No RCC recurrence was observed.
CONCLUSION
Patients with early-stage and asymptomatic RCC do not require a mandatory observational period prior to KT after curative nephrectomy

Keyword

End-stage renal disease; Kidney transplantation; Recurrence; Renal cell carcinoma; Survival

MeSH Terms

Asian Continental Ancestry Group
Carcinoma, Renal Cell*
Graft Rejection
Graft Survival
Humans
Kidney Failure, Chronic
Kidney Transplantation
Kidney*
Nephrectomy
Recurrence
Retrospective Studies
Transplant Recipients*
Full Text Links
  • KRCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr